Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/new-frontiers-in-hypofractionation-for-regional-nodal-irradiation-in-A8rVeKFL3A
References (55)
-
A. Ho, A. Ballangrud, Guang Li, Yuchun Chen, K. Krause, B. McCormick, S. Powell (2013)
Pneumonitis Rates Following Comprehensive Nodal Irradiation in Breast Cancer Patients: Results of a Phase 1 Feasibility Trial of Intensity Modulated Radiation TherapyInternational Journal of Radiation Oncology Biology Physics, 87
-
A. Ho, A. Ballangrud, Guang Li, G. Gupta, B. McCormick, R. Gewanter, D. Gelblum, M. Zinovoy, B. Mueller, B. Mychalczak, P. Dutta, Karen Borofsky, P. Parhar, M. Reyngold, L. Braunstein, M. Chawla, K. Krause, N. Freeman, C. Siu, Zachary Cost, B. Arnold, Zhigang Zhang, S. Powell (2019)
Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.International journal of radiation oncology, biology, physics, 103 5
-
S. Bentzen, R. Agrawal, E. Aird, J. Barrett, P. Barrett-Lee, J. Bliss, Janet Brown, J. Dewar, H. Dobbs, J. Haviland, Peter Hoskin, P. Hopwood, P. Lawton, B. Magee, J. Mills, D. Morgan, Owen, S. Simmons, G. Sumo, M. Sydenham, K. Venables, Yarnold (2008)
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialThe Lancet. Oncology, 9
-
C. Popescu, I. Olivotto, W. Beckham, W. Ansbacher, S. Zavgorodni, R. Shaffer, E. Wai, K. Otto (2010)
Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes.International journal of radiation oncology, biology, physics, 76 1
-
N. Mohan, Jiangsong Jiang, Milos Dokmanovic, W. Wu (2018)
Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers.Antibody therapeutics, 1 1
-
H. Versmessen, V. Vinh-Hung, Hilde Parijs, Geertje Miedema, M. Voordeckers, N. Adriaenssens, G. Storme, M. Ridder (2012)
Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapyBMC Cancer, 12
-
T. Whelan, J. Pignol, M. Levine, J. Julian, R. Mackenzie, S. Parpia, W. Shelley, L. Grimard, J. Bowen, H. Lukka, F. Perera, A. Fyles, K. Schneider, S. Gulavita, C. Freeman (2010)
Long-term results of hypofractionated radiation therapy for breast cancer.The New England journal of medicine, 362 6
-
J. Owen, A. Ashton, J. Bliss, J. Homewood, C. Harper, J. Hanson, J. Haviland, S. Bentzen, J. Yarnold (2006)
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial.The Lancet. Oncology, 7 6
-
(2019)
De-intesnify radiotherapy with hypofractionation may reduce acute & short-term toxicity in breast cancer -
A. Neri, D. Marrelli, F. Roviello, A. Stefano, A. Guarnieri, E. Pallucca, E. Pinto (2005)
Prognostic Value of Extracapsular Extension of Axillary Lymph Node Metastases in T1 to T3 Breast CancerAnnals of Surgical Oncology, 12
-
Adrian Brunt, J. Haviland, Duncan Wheatley, M. Sydenham, A. Alhasso, D. Bloomfield, Charlie Chan, Mark Churn, Suzy Cleator, Charlotte Coles, A. Goodman, A. Harnett, Penelope Hopwood, A. Kirby, C. Kirwan, Carolyn Morris, Z. Nabi, Elinor Sawyer, Navita Somaiah, L. Stones, I. Syndikus, Judith Bliss, John Yarnold, Abdulla Cha, A. Alhasso, A. Armstrong, Judith Bliss, D. Bloomfield, J. Bowen, M. Brunt, Charlie Chan, H. Chantler, Mark Churn, Suzy Cleator, Charlotte Coles, E. Donovan, A. Goodman, S. Griffin, J. Haviland, Penelope Hopwood, A. Kirby, J. Kirk, C. Kirwan, M. Maclennan, Carolyn Morris, Z. Nabi, Elinor Sawyer, M. Sculphur, J. Sinclair, Navita Somaiah, L. Stones, M. Sydenham, I. Syndikus, Jean Tremlett, K. Venables, Duncan Wheatley, John Yarnold (2020)
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trialLancet (London, England), 395
-
R. Jagsi, Jing Jiang, Adeyiza Momoh, A. Alderman, S. Giordano, T. Buchholz, L. Pierce, S. Kronowitz, Benjamin Smith (2016)
Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based AnalysisAnnals of Surgery, 263
-
L. Warren, Cynthia Miller, N. Horick, Melissa Skolny, Lauren Jammallo, Betro Sadek, Mina Shenouda, J. O’Toole, S. MacDonald, M. Specht, A. Taghian (2014)
The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study.International journal of radiation oncology, biology, physics, 88 3
-
Cynthia Miller, M. Specht, Melissa Skolny, N. Horick, Lauren Jammallo, J. O’Toole, Mina Shenouda, Betro Sadek, Barbara Smith, A. Taghian (2014)
Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patientsBreast Cancer Research and Treatment, 144
-
R. Agrawal, E. Aird, J. Barrett, P. Barrett-Lee, S. Bentzen, J. Bliss, Julia Brown, J. Dewar, H. Dobbs, J. Haviland, Peter Hoskin, P. Hopwood, P. Lawton, B. Magee, J. Mills, D. Morgan, J. Owen, S. Simmons, G. Sumo, M. Sydenham, K. Venables, J. Yarnold (2008)
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialLancet, 371
-
K. Rastogi, Sandeep Jain, A. Bhatnagar, S. Bhaskar, Shivani Gupta, Neeraj Sharma (2018)
A Comparative Study of Hypofractionated and Conventional Radiotherapy in Postmastectomy Breast Cancer PatientsAsia-Pacific Journal of Oncology Nursing, 5
-
Financial toxicity : a growing burden for cancer patients -
(2018)
Similar locoregional recurrences and overall survival among patients undergoing postmastectomy radiation using conventional fractionations or hypofractionation regimen was -
M. Overgaard, H. Nielsen, J. Overgaard (2007)
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 82 3
-
S. Johansson, H. Svensson, L. Larsson, J. Denekamp (2000)
Brachial Plexopathy After Postoperative Radiotherapy of Breast Cancer Patients: A Long-Term Follow-upActa Oncologica, 39
-
Kristy Kummerow, L. Du, D. Penson, Y. Shyr, M. Hooks (2015)
Nationwide trends in mastectomy for early-stage breast cancer.JAMA surgery, 150 1
-
M. Specht, Cynthia Miller, T. Russell, N. Horick, Melissa Skolny, J. O’Toole, Lauren Jammallo, A. Niemierko, Betro Sadek, Mina Shenouda, D. Finkelstein, Barbara Smith, A. Taghian (2013)
Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?Breast Cancer Research and Treatment, 140
-
J. Stjernswärd (1974)
Decreased survival related to irradiation postoperatively in early operable breast cancer.Lancet, 2 7892
-
D. Vassard, M. Olsen, L. Zinckernagel, J. Vibe-Petersen, S. Dalton, C. Johansen (2010)
Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort study.European journal of cancer, 46 18
-
J. Ragaz, I. Olivotto, J. Spinelli, N. Phillips, S. Jackson, K. Wilson, M. Knowling, C. Coppin, L. Weir, K. Gelmon, N. Le, Ralph Durand, A. Coldman, M. Manji (2005)
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.Journal of the National Cancer Institute, 97 2
-
N. Smith, K. Jethwa, J. Viehman, W. Harmsen, K. Gonuguntla, Sarah Elswick, Jennifer Grauberger, A. Amundson, T. Whitaker, N. Remmes, C. Harless, J. Boughey, M. Nguyen, Sean Park, K. Corbin, R. Mutter (2019)
Post-mastectomy intensity modulated proton therapy after immediate breast reconstruction: Initial report of reconstruction outcomes and predictors of complications.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 140
-
A. Pusic, Y. Cemal, C. Albornoz, A. Klassen, S. Cano, Isabel Sulimanoff, Marisol Hernandez, M. Massey, P. Cordeiro, M. Morrow, B. Mehrara (2013)
Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomesJournal of Cancer Survivorship, 7
-
(2020)
Cancer Facts & Figures -
(2017)
MC1631 – a randomized trial of 15 versus 25 fraction proton post-mastectomy radiotherapy (PMRT): initial planning and acute toxicity outcomes -
J. Yarnold, S. Bentzen, C. Coles, J. Haviland (2011)
Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities.International journal of radiation oncology, biology, physics, 79 1
-
W. Gradishar, B. Anderson, J. Abraham, R. Aft, D. Agnese, K. Allison, S. Blair, H. Burstein, C. Dang, A. Elias, S. Giordano, M. Goetz, L. Goldstein, S. Isakoff, J. Krishnamurthy, J. Lyons, P. Marcom, J. Matro, I. Mayer, M. Moran, J. Mortimer, R. O'Regan, Sameer Patel, L. Pierce, H. Rugo, Amy Sitapati, K. Smith, Mary Smith, H. Soliman, E. Stringer-Reasor, M. Telli, John Ward, Jessica Young, J. Burns, Rashmi Kumar (2020)
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network : JNCCN, 18 4
-
Shulian Wang, H. Fang, Yong-wen Song, Weihu Wang, Chen Hu, Yueping Liu, J. Jin, Xin-fan Liu, Zi-hao Yu, H. Ren, Ning Li, N. Lu, Yu Tang, Yuan Tang, S. Qi, G. Sun, R. Peng, Shuai Li, Bo Chen, Yong Yang, Ye‐Xiong Li (2019)
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.The Lancet. Oncology, 20 3
-
Hilde Parijs, Geertje Miedema, V. Vinh-Hung, S. Verbanck, N. Adriaenssens, D. Kerkhove, T. Reynders, D. Schuermans, K. Leysen, S. Hanon, G. Camp, W. Vincken, G. Storme, D. Verellen, M. Ridder (2012)
Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trialRadiation Oncology (London, England), 7
-
Sriram Venigalla, D. Guttmann, V. Jain, Sonam Sharma, G. Freedman, J. Shabason (2018)
Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database AnalysisClinical Breast Cancer, 18
-
R. Jimenez, S. Hickey, N. Depauw, B. Yeap, E. Batin, M. Gadd, M. Specht, S. Isakoff, Barbara Smith, E. Liao, A. Colwell, A. Ho, J. Januzzi, J. Passeri, T. Neilan, A. Taghian, Hsiao-Ming Lu, S. MacDonald (2019)
Phase II Study of Proton Beam Radiation Therapy for Patients With Breast Cancer Requiring Regional Nodal Irradiation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
S. Siddharth, D. Sharma (2018)
Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic DeterminantsCancers, 10
-
M. Koukourakis, Marianthi Panteliadou, I. Abatzoglou, Kyriaki Sismanidou, E. Sivridis, A. Giatromanolaki (2013)
Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection.International journal of radiation oncology, biology, physics, 85 1
-
D. Pfister, K. Ang, D. Brizel (2012)
National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology -
A. Recht, S. Edge, L. Solin, D. Robinson, A. Estabrook, R. Fine, G. Fleming, S. Formenti, C. Hudis, J. Kirshner, David Krause, R. Kuske, A. Langer, G. Sledge, Timothy Whelan, D. Pfister (2001)
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 5
-
M. Overgaard, M. Jensen, J. Overgaard, P. Hansen, C. Rose, M. Andersson, C. Kamby, M. Kjaer, C. Gadeberg, B. Rasmussen, M. Blichert‐Toft, H. Mouridsen (1999)
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trialThe Lancet, 353
-
(2020)
This study suggests a low mean heart dose is feasible despite coverage of internal mammary node in the cohort of patients undergoing hypofractionated post-mastectomy radiation -
E. Krueger, B. Fraass, D. McShan, R. Marsh, L. Pierce (2003)
Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy.International journal of radiation oncology, biology, physics, 56 4
-
N. Ohri, M. Sittig, C. Tsai, E. Hwang, E. Mittendorf, W. Shi, Zhigang Zhang, A. Ho (2018)
Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysisCancer, 124
-
M. Danko, Kyla Bennett, J. Zhai, J. Marks, J. Olson (2010)
Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up.Journal of the American College of Surgeons, 210 5
-
J. Cuzick, H. Stewart, L. Rutqvist, J. Houghton, R. Edwards, C. Redmond, R. Peto, M. Baum, B. Fisher, H. Høst (1994)
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 3
-
A. Alderman, E. Wilkins, Hyungjin Kim, J. Lowery (2002)
Complications in Postmastectomy Breast Reconstruction: Two‐Year Results of the Michigan Breast Reconstruction Outcome StudyPlastic and Reconstructive Surgery, 109
-
M. Overgaard, P. Hansen, J. Overgaard, C. Rose, M. Andersson, F. Bach, M. Kjaer, C. Gadeberg, H. Mouridsen, M. Jensen, K. Zedeler (1997)
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.The New England journal of medicine, 337 14
-
V. Dumane, K. Saksornchai, Ying Zhou, L. Hong, S. Powell, A. Ho (2018)
Reduction in low-dose to normal tissue with the addition of deep inspiration breath hold (DIBH) to volumetric modulated arc therapy (VMAT) in breast cancer patients with implant reconstruction receiving regional nodal irradiationRadiation Oncology (London, England), 13
-
T. DiSipio, Sheree Rye, B. Newman, S. Hayes (2013)
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.The Lancet. Oncology, 14 6
-
Rebecca Tsai, L. Dennis, C. Lynch, L. Snetselaar, G. Zamba, C. Scott-Conner (2009)
The Risk of Developing Arm Lymphedema Among Breast Cancer Survivors: A Meta-Analysis of Treatment FactorsAnnals of Surgical Oncology, 16
-
A. Pinitpatcharalert, I. Chitapanarux, J. Euathrongchit, E. Tharavichitkul, V. Sukthomya, V. Lorvidhaya (2011)
A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer.Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 94 Suppl 2
-
M. Clarke, R. Collins, S. Darby, C. Davies, P. Elphinstone, V. Evans, J. Godwin, R. Gray, C. Hicks, S. James, E. Mackinnon, P. Mcgale, T. McHugh, R. Peto, Carolyn Taylor, Yaochen Wang (2005)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 366
-
Atif Khan, M. Poppe, S. Goyal, K. Kokeny, T. Kearney, L. Kirstein, D. Toppmeyer, D. Moore, Chunxia Chen, D. Gaffney, B. Haffty (2017)
Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 18
-
M. Poppe, Z. Yehia, C. Baker, S. Goyal, D. Toppmeyer, L. Kirstein, Chunxia Chen, D. Moore, B. Haffty, Atif Khan (2020)
5-year Update of a Multi Institution Prospective Phase II Hypofractionated Post-Mastectomy Radiation Therapy Trial.International journal of radiation oncology, biology, physics
-
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
- Publisher
- Springer Journals
- Copyright
- Copyright © Springer Science+Business Media, LLC, part of Springer Nature 2020
- ISSN
- 1943-4588
- eISSN
- 1943-4596
- DOI
- 10.1007/s12609-020-00385-w
- Publisher site
- See Article on Publisher Site
Abstract
Purpose of ReviewIn recent years, there have been a number of small, yet notable practice changes in the delivery of postmastectomy radiation therapy (PMRT) in breast cancer patients. Herein, we describe the role of PMRT and its evolving delivery with hypofractionated regimens.Recent FindingsThe UK START trials and whole-breast hypofractionation studies established the safety and effectiveness of accelerated radiotherapy. This has inspired further investigations of similar principles in patients with reconstruction, acute and late toxicities associated with hypofractionated regimens, socioeconomic benefit, and evolving delivery techniques.SummaryOverall, results from clinical trials evaluating hypofractionation for RNI or PMRT appear promising despite the limited length of follow-up. Ongoing clinical trials will provide valuable data on the safety of hypofractionation in breast cancer patients with immediate reconstruction. Hypofractionation for PMRT represents high-quality care that is not only more convenient for patients but also more cost-effective for the healthcare system.
Journal
Current Breast Cancer Reports – Springer Journals
Published: Oct 27, 2020